Italia markets closed

BMY May 2024 45.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,35000,0000 (0,00%)
Alla chiusura: 03:59PM EDT
Schermo intero
Chiusura precedente0,3500
Aperto0,3900
Denaro0,3500
Lettera0,4500
Prezzo d'esercizio45,00
Scadenza2024-05-17
Min-Max giorno0,3300 - 0,5300
Contratto - Min-MaxN/D
Volume148
Open Interest2,5k
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri